1. Biographies

   Acknowledgments 22 December 2009 Pages: 265 - 266

   

2. Preface

   • David J. McConkey
   • Colin Dinney

   EditorialNotes 16 December 2009 Pages: 267 - 267

3. Genome-wide association studies of bladder cancer risk: a field synopsis of progress and potential applications

   • Xifeng Wu
   • Michelle A. T. Hildebrandt
   • David W. Chang

   OriginalPaper 18 December 2009 Pages: 269 - 280

   

4. Biology of urothelial tumorigenesis: insights from genetically engineered mice

   • Xue-Ru Wu

   OriginalPaper Open access 11 December 2009 Pages: 281 - 290

   

5. Urothelial carcinoma: Stem cells on the edge

   • William D. Brandt
   • William Matsui
   • David M. Berman

   OriginalPaper 11 December 2009 Pages: 291 - 304

   

6. Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer

   • Margaret A. Knowles
   • Fiona M. Platt
   • Carolyn D. Hurst

   OriginalPaper Open access 16 December 2009 Pages: 305 - 316

   

7. Strategies for molecular expression profiling in bladder cancer

   • Anirban P. Mitra
   • Claudia C. Bartsch
   • Richard J. Cote

   OriginalPaper 08 December 2009 Pages: 317 - 326

   

8. Pathways of metastasis suppression in bladder cancer

   • Neveen Said
   • Dan Theodorescu

   OriginalPaper 16 December 2009 Pages: 327 - 333

   

9. Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer

   • David J. McConkey
   • Woonyoung Choi
   • Colin Dinney

   OriginalPaper 14 December 2009 Pages: 335 - 344

   

10. The role of neutrophils and TNF-related apoptosis-inducing ligand (TRAIL) in bacillus Calmette–Guérin (BCG) immunotherapy for urothelial carcinoma of the bladder

    • Henry M. Rosevear
    • Andrew J. Lightfoot
    • Thomas S. Griffith

    OriginalPaper 05 December 2009 Pages: 345 - 353

    

11. Emerging targeted therapies for bladder cancer: a disease waiting for a drug

    • Simon J. Dovedi
    • Barry R. Davies

    OriginalPaper 10 December 2009 Pages: 355 - 367

    

12. MicroRNA function in cancer: oncogene or a tumor suppressor?

    • Sylvia K. Shenouda
    • Suresh K. Alahari

    NON-THEMATIC REVIEW 14 December 2009 Pages: 369 - 378